The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms

Authors

H.A. Emsellem

Document Type

Journal Article

Publication Date

2003

Journal

Sleep

Volume

26

Issue

2

Inclusive Pages

131-135

Keywords

Neurology

APA Citation

Emsellem, H. (2003). The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms. Sleep, 26 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_neuro_facpubs/605